导航治疗方法,挑战和治疗耐药产前抑郁症的建议:全面审查
Afshan Zeeshan Wasti1, Sarah Almutairi1, Mohsina Huq1
1Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia.
Healthcare (Basel, Switzerland)
|October 16, 2025
概括
耐治疗的周周抑郁症 (TRPD) 需要谨慎管理. 像CBT和运动这样的非药物疗法为药物提供了安全的替代品,平衡母亲健康和婴儿安全.
科学领域:
- 围产阶段精神病学 围产阶段精神病学
- 神经科学是一个神经科学.
- 临床心理学 临床心理学
背景情况:
- 耐治疗的周周抑郁症 (TRPD) 在全球面临重大挑战.
- 与胎儿/新生儿安全平衡孕产妇的症状缓解至关重要.
研究的目的:
- 审查TRPD目前的药理和非药理干预措施.
- 突出治疗的机制,疗效,安全性和实际考虑.
主要方法:
- 从2000年到2024年进行系统的文献搜索 (PubMed,科克伦图书馆,EMBASE).
- 对于142篇初始文章的选和质量评估,遵循了PRISMA指南,其中包括67篇.
- 结合了TRD/TRPD的MeSH和自由文本术语.
主要成果:
- 药理选择 (SSRI,布雷克萨诺龙,祖拉诺龙) 显示有效性,但携带胎儿/新生儿风险.
- 非药物干预 (CBT,rTMS,运动) 提供了安全的,基于证据的替代方案.
- 个性化,综合的方法是平衡孕产妇控制和围产安全的最佳方法.
结论:
- 创新的治疗方法和综合干预措施是最佳TRPD护理的关键.
- 扩大心理健康基础设施和加强研究至关重要.
- 非药理学方法为安全有效的TRPD管理提供了有希望的途径.
相关概念视频
Psychosis: Goals of Pharmacotherapy
466
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
466
Electroconvulsive Therapy
864
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
864
Antidepressant Drugs: MAOIs and Other Agents
806
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
806
Depression: Overview
777
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
777
Drug Therapy
239
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
239
Depressive Disorders: Etiology
437
Depressive disorders result from a complex interplay of biological, psychological, and sociocultural factors, each contributing uniquely to the development and persistence of the condition. Understanding these factors provides critical insight into the multifaceted nature of depression.
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
Biological Factors in Depression
Biological predispositions significantly influence the risk of developing depressive disorders. Genetic studies highlight the role of variations in the serotonin transporter...
437


